Monday, May 18, 2015

Endo to Buy Par Pharma

Endo International agreed to buy Par Pharmaceutical from private-equity firm TPG for about $8 billion in a cash-and-stock deal that will help boost its generics business.

from WSJ.com: US Business http://ift.tt/1B7ogAz
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)